Workflow
第一医药: 上海第一医药股份有限公司关于2024年度暨2025年第一季度业绩说明会召开情况的公告

Group 1 - The company held a performance briefing for the fiscal year 2024 and the first quarter of 2025 on June 13, 2025, via the Shanghai Stock Exchange's online platform [1] - Key executives, including the Chairman and General Manager, participated in the briefing to discuss the company's operational results and financial metrics with investors [2] - The company is focusing on enhancing its service capabilities and operational efficiency through digitalization and innovation, while also maintaining a commitment to cash dividends for investors [2] Group 2 - The company has established a strategic and ESG committee to integrate ESG governance into its board management, and it has been recognized for its ESG performance with an A rating in the market [2] - The company has been actively involved in various health-related retail formats, including health stations targeting young mothers and comprehensive health towns offering a range of health products and services [2] - The company has received accolades such as the "2024 Whale Award" for being an ESG newcomer, highlighting its commitment to sustainable development [2]